Press releasePRNewswire
Insight Molecular Diagnostics
OCX · NASDAQ
$3.03+$0.14 (+4.84%)TodayMarket closed ·
Prev close $2.89
OCX key statistics
- Market cap
- —
- Price-earnings ratio
- —
- Dividend yield
- —
- Average volume
- 22.72K
- Volume
- 271.09K
- Open price
- $2.96
- High today
- $3.28
- Low today
- $2.96
- 52 Week high
- $3.57
- 52 Week low
- $3.30
Insight Molecular Diagnostics (OCX) at a glance
As of Oct 20, 2026, Insight Molecular Diagnostics (OCX) shares are priced at $3.03.
Today the stock has traded between $2.96 and $3.28. The current price is 2.4% above the day's low and 7.5% below its high.
Volume so far is 271.09K shares, above the average of 22.72K shares a day.
Over the past year Insight Molecular Diagnostics has ranged from $3.30 to $3.57, and now sits -100% of the way up that range.
OCX news
- Press releaseBusiness Wire
STAAR Surgical Announces Changes to Board of Directors
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Press releaseGlobe Newswire
Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts
- Press releaseBusiness Wire
Veradigm Announces Board Expansion and Changes
What to Expect from OncoCyte's Earnings
- Press releaseGlobe Newswire
PRISM MarketView Features Oncocyte CFO Andrea S. James on Her Career and Leadership in Molecular Diagnostics Technology
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.